The Norwegian Cancer Symposium 2020


-       from a prostate cancer perspective

September 17th-18th, 2020
Oslo, Norway

This 2-day symposium brings together top-ranking researchers, clinicians, industry and policymakers.  We aim to strengthen collaboration and overcome hurdles for implementing molecular tests in precision medicine.

Registration deadline June 1st 2020

We are following the Corona situation and we will give you updated information on April 16th 2020 if the deadlines are extended.

Stacy Loeb (US)
Nicolas Mottet (FR)
Derya Tilki (DE)
Himisha Beltran (US)
Johann de Bono (UK)
Jason Connor (US)
Henrik Grönberg (SE)
Ian Mills (UK)
Rob Bristow (UK)
Wytske van Weerden (NL)
Olli Kallioniemi (SE)
Arul Chinnaiyan (US)
Mark A. Rubin (CH)
Guido Jenster (NL)
Johan Skog (US)
Hege Russnes (NO)
Johanna Olweus (NO)
Håvard Danielsen (NO)
Heidi Lyng (NO)
Rolf I Skotheim (NO)
Show More

The speakers will cover topics on how molecular tests can enable sustainable and cost-effective precision in the clinic, how to exploit the complex interplay between tumour and microenvironment, and tools to discover and validate clinically relevant biomarkers.